Intrauterine device use among women with ovarian cancer: a systematic review

Contraception

Volumn 82, Issue 1, 2010, Pages 38-40

  Zapata, Lauren B ^a   Whiteman, Maura K ^a   Marchbanks, Polly A ^a   Curtis, Kathryn M ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Immunosuppression; Intrauterine device; Ovarian cancer; Ovarian neoplasm

Indexed keywords

COPPER; LEVONORGESTREL;

CANCER CHEMOTHERAPY; CLINICAL TRIAL; DISEASE COURSE; EVIDENCE BASED MEDICINE; FEMALE; HORMONAL CONTRACEPTION; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MEDLINE; OUTCOME ASSESSMENT; OVARY CANCER; PATIENT SAFETY; PELVIC INFLAMMATORY DISEASE; REVIEW; RISK ASSESSMENT; SEX CORD TUMOR; SYSTEMATIC REVIEW; VAGINA BLEEDING;

ADULT; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS; INTRAUTERINE DEVICES; INTRAUTERINE DEVICES, COPPER; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; OVARIAN NEOPLASMS;

EID: 77953025130     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.02.013     Document Type: Review

References (15)

1. American Cancer Society. Ovarian cancer. Atlanta (Ga): American Cancer Society. Accessed November 12, 2008 (2008). http://documents.cancer.org/114.00/114.00.pdf
2. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA: A Cancer J Clin 58 (2008) 71-96
3. Horner M., Ries L., Krapcho M., et al. SEER cancer statistics review, 1975-2006. Bethesda (Md): National Cancer Institute. Accessed September 25, 2009 (2009). http://seer.cancer.gov/csr/1975_2006/results_merged/sect_21_ovary.pdf
4. Chen V.W., Ruiz B., Killeen J.L., Cote T.R., Wu X.C., and Correa C.N. Pathology and classification of ovarian tumors. Cancer 97 (2003) 2631-2642
5. Chen L., and Berek J.S. Epithelial ovarian cancer: clinical manifestations, diagnostic evaluation, staging, and histopathology. In: Basow D.S. (Ed). UpToDate (2008), UpToDate, Waltham (Mass)
6. Chen L.M., and Berek J.S. Ovarian tumors of low malignant potential. In: Basow D.S. (Ed). UpToDate (2008), UpToDate, Waltham (Mass)
7. Eltabbakh G.H., Natarajan N., Piver S., and Mettlin C.J. Epidemiologic differences between women with borderline ovarian tumors and women with epithelial ovarian cancer. Gynecol Oncol 74 (1999) 103-107
8. Bast R.C., Hennessy B., and Mills G.B. The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer 9 (2009) 415-428
9. Dorigo O., and Berek J.S. Sex cord-stromal tumors of the ovary. In: Basow D.S. (Ed). UpToDate (2008), UpToDate, Waltham (Mass)
10. Goodman M.T., Correa C.N., Tung K., et al. Stage at diagnosis of ovarian cancer in the United States, 1992-1997. Cancer 97 (2003) 2648-2659
11. Ries L., Melbert D., Krapcho M., et al. SEER cancer statistics review, 1975-2005. Bethesda (Md): National Cancer Institute. Accessed November 12, 2008 (2008). http://seer.cancer.gov/csr/1975_2005
12. Mann W.J., Chalas E., and Valea F.A. Initial surgical management of epithelial ovarian cancer. In: Basow D.S. (Ed). UpToDate (2008), UpToDate, Waltham (Mass)
13. Browne H., Manipalviratn S., and Armstrong A. Using an intrauterine device in immunocompromised women. Obstet Gynecol 112 (2008) 667-669
14. World Health Organization. Medical eligibility criteria for contraceptive use. 3rd ed. (2004), World Health Organization, Geneva
15. World Health Organization. Medical eligibility criteria for contraceptive use, 2008 update. Geneva: World Health Organization. Accessed July 9, 2009 (2009). http://whqlibdoc.who.int/hq/2008/WHO_RHR_08.19_eng.pdf